Pravachol News
Under the Weather - Therapeutics Daily (subscription) (press release)
Pravachol was the bestseller for Bristol-Myers Squibb for more than a decade. But in these and other cases it was Japanese discoveries that led to Western ...
Earnings Preview: Bristol-Myers Squibb - Houston Chronicle
"Growth from Plavix should be bolstered by income from Abilify (schizophrenia) and Reyataz (HIV infection), but the loss of Pravachol exclusivity will ...
Bristol-Myers Squibb Company Reports Financial Results for the ... - CNNMoney.com
... Pharmaceuticals Cardiovascular Plavix $4755 $3257 46 % 4060 2655 53 % 34 % Avapro/Avalide 1204 1097 10 % 692 647 7 % (4)% Pravachol 443 1197 (63)% 139 ...
B-MS posts loss and counts cost of subprime investments - Pharma Times (subscription)
On the negative side, generic competition battered sales of cholesterol-lowerer Pravachol (pravastatin), which fell 38% to $90 million, while anticancer ...
Under The Radar News - Tuesday - Seeking Alpha
Statins, including Pfizer's (PFE) Lipitor, AstraZeneca's (AZN) Crestor, and Bristol-Myers's (BMY) Pravachol, don't seem to prolong the lives of all people ...
Genetic Variant Predicts Heart Disease Risk - MIT Technology Review
The researchers also found that carriers of the KIF6 variant responded better to the cholesterol-lowering drugs pravastatin (Pravachol) and atorvastatin ...
Merck, Schering-Plough defend drug study - CNNMoney.com
The statins Lipitor, Zocor, Pravachol, Lescol and Mevacor all have been proven in testing to reduce those risks, as has the drug niacin, according to FDA. ...
Statin Drugs: Bad News Gets Worse - NewsMax.com
The drugs tested in this study included Lipitor, Mevacor and Pravachol. Chronic immune suppression in these millions would mean that a tremendous number ...
Great Drug, but Does It Prolong Life? - New York Times
Some patients do receive significant benefits from statins, like Lipitor (from Pfizer), Crestor (AstraZeneca) and Pravachol (Bristol-Myers Squibb). ...
Celera Publishes Three Papers Demonstrating That Carriers of a ... - Business Wire (press release)
These research studies also showed that the excess risk associated with the KIF6 variant was virtually eliminated by pravastatin (Pravachol®) therapy and ...
Pravachol RSS Feed